Literature DB >> 24417793

Correlation between distribution of muscle weakness, electrophysiological findings and CTG expansion in myotonic dystrophy.

Roya Khoshbakht1, Akbar Soltanzadeh1, Babak Zamani1, Siyamak Abdi1, Kourosh Gharagozli2, Kimia Kahrizi3, Rahem Khoshbakht4, Shahriar Nafissi5.   

Abstract

Myotonic dystrophy type 1 (DM-1) is a multi-system disorder affecting the muscles, brain, cardiovascular system, endocrine system, eyes and skin. Diagnosis is made by clinical, electrodiagnostic and genetic studies. This study aimed to determine the correlation between CTG expansion and distribution of muscle weakness and clinical and electrophysiological findings. Genetically confirmed DM-1 patients presenting to Shariati Hospital between 2005 and 2011 were included in this study. Clinical, electrodiagnostic and genetic testing was performed and the correlation between CTG expansion and distribution of muscle weakness and clinical and electromyographic findings was studied. Thirty-three genetically confirmed DM-1 patients were enrolled. Myotonia, bifacial weakness and distal upper limb weakness were seen in all patients. Diabetes mellitus was found in one patient (3%), cardiac disturbance in eight (24.2%), cataracts in eight (24.2%), hypogonadism in five (15.2%), frontal baldness in 13 (39.4%), temporalis wasting in 14 (42.4%), temporomandibular joint disorder in seven (21.2%) and mental retardation in eight (24.2%). The mean number of CTG repeats, measured by Southern blot, was 8780 (range 500-15,833). A negative correlation was found between CTG expansion and age of onset. Temporalis wasting and mental retardation were positively correlated with CTG expansion. No relationship was found between weakness distribution, electromyographic findings, other systemic features and CTG expansion. In this study of DM-1 in Iran, we found a correlation between CTG expansion and age of onset, temporalis wasting and mental disability. No correlation between CTG expansion and electrodiagnostic and other clinical findings were detected.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CTG expansion; Clinical manifestation; Exercise; Myotonic dystrophy

Mesh:

Substances:

Year:  2013        PMID: 24417793     DOI: 10.1016/j.jocn.2013.09.016

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

1.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

2.  Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity.

Authors:  Simona Portaro; Antonino Naro; Antonino Chillura; Luana Billeri; Alessia Bramanti; Placido Bramanti; Carmelo Rodolico; Rocco Salvatore Calabrò
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 3.  Brain Activity Underlying Muscle Relaxation.

Authors:  Kouki Kato; Tobias Vogt; Kazuyuki Kanosue
Journal:  Front Physiol       Date:  2019-12-03       Impact factor: 4.566

4.  Electrodiagnostic findings in myotonic dystrophy: A study on 12 patients.

Authors:  Ahmet Z Burakgazi
Journal:  Neurol Int       Date:  2019-12-02

Review 5.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05

6.  ATXN2 trinucleotide repeat length correlates with risk of ALS.

Authors:  William Sproviero; Aleksey Shatunov; Daniel Stahl; Maryam Shoai; Wouter van Rheenen; Ashley R Jones; Safa Al-Sarraj; Peter M Andersen; Nancy M Bonini; Francesca L Conforti; Philip Van Damme; Hussein Daoud; Maria Del Mar Amador; Isabella Fogh; Monica Forzan; Ben Gaastra; Cinzia Gellera; Aaron D Gitler; John Hardy; Pietro Fratta; Vincenzo La Bella; Isabelle Le Ber; Tim Van Langenhove; Serena Lattante; Yi-Chung Lee; Andrea Malaspina; Vincent Meininger; Stéphanie Millecamps; Richard Orrell; Rosa Rademakers; Wim Robberecht; Guy Rouleau; Owen A Ross; Francois Salachas; Katie Sidle; Bradley N Smith; Bing-Wen Soong; Gianni Sorarù; Giovanni Stevanin; Edor Kabashi; Claire Troakes; Christine van Broeckhoven; Jan H Veldink; Leonard H van den Berg; Christopher E Shaw; John F Powell; Ammar Al-Chalabi
Journal:  Neurobiol Aging       Date:  2016-11-24       Impact factor: 5.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.